Comprehensive interpretation of Cabergoline

Cabergoline, identified in English asCabergoline, is a medicinal compound that has attracted much attention in the medical community. Its unique medicinal value and excellent performance in treating specific diseases have made it a hot topic in medical research today. Next, we’ll take an in-depth look at various aspects of cabergoline:

1. Overview of basic information

Cabergoline, its chemical structure consists ofC26H37N5O2, with a molecular weight of 451.62.

2. Core application areas

Cabergoline plays a pivotal role in the treatment of hyperprolactinemia, especially for patients with hyperprolactinemia caused by primary causes or pituitary tumors. It is an indispensable therapeutic drug. However, to ensure its safety and effectiveness, patients must use it under the guidance of a professional physician.

3. Explanation of the principle of action

Cabergoline is a long-acting dopamine receptor agonist. It binds closely to and activates D2 receptors, thereby effectively inhibiting various secretory functions of the pituitary gland, especially the secretion of prolactin. This unique mechanism allows cabergoline to perform well in the treatment of conditions such as hyperprolactinemia.

4. Medication guidance

During the initial treatment phase, patients are recommended to take 0.25 mg of cabergoline twice a week. Physicians will adjust the dose based on the patient's serum prolactin concentration. The dose can be increased by 0.25 mg twice a week, up to a maximum of 1 mg twice a week. Before initiating treatment, a thorough assessment of the patient's cardiovascular status should be performed, and echocardiography should be considered to screen for underlying valvular disease. To ensure patient safety, dose increases should be no more frequent than every 4 weeks so that physicians can accurately assess the patient's physiological response at different doses. If the patient still does not experience significant effects after increasing the dose, the lowest dose that can produce the best therapeutic effect should be selected and other treatments should be considered. For patients who require long-term cabergoline treatment, their heart health should be regularly evaluated and periodic echocardiograms should be considered. When the patient's serum prolactin levels remain stable for six months, cabergoline can be discontinued and serum prolactin levels monitored periodically to determine if and when the cabergoline regimen needs to be restarted. Of note, there is a lack of conclusive research data on the durability of cabergoline's effects beyond 24 months.

5. Potential risks and prevention suggestions

Although cabergoline has significant therapeutic effects, side effects such as gastrointestinal upset, allergic reactions, or headaches may occur during use. Patients should strictly follow the physician's medication instructions when using cabergoline and pay close attention to their own body reactions.

It is understood that cabergoline is only sold in overseas markets. A box of the original drug costs about several hundred yuan, while the Indian version of the generic drug is slightly cheaper, about one or two hundred yuan per box.